This is not well-studied in clinical trials, but real-world data suggests it is common
By activating both receptors, oxyntomodulin increases energy expenditure, reduces appetite, promotes weight loss, and improves glucose tolerance, showcasing the therapeutic potential of this dual mechanism [79]
Later development introduced glucagon receptor activity into the same peptide framework, leading to triple-agonist compounds like Retatrutide for more integrated pathway research
Ghrelin (the hunger hormone) increases with sleep deprivation while leptin (the satiety hormone) decreases
And we're only getting started
found that neither normal nor hyperplastic human thyroids containing parafollicular C cells express GLP-1 receptors (73)